CK13 is an epithelial CK already used as an immunotarget agent for oral intraepithelial neoplasia, more recently its expression with CK17 has been evaluated as an immunotarget for vulvar intraepithelial neoplasia as well. The gene discussed is KRT17; the disease is vulvar intraepithelial neoplasia.